Charles River Laboratories and Autolomous Launch Apollo Orchestrate To Digitize Laboratory Execution Through autoloMATE Integration
10/6/2026
Impact: 75
Healthcare
Charles River Laboratories (NYSE: CRL) and Autolomous have launched Apollo Orchestrate, a new feature within Charles River's Apollo platform that integrates Autolomous's autoloMATE digital Laboratory Execution System. This initiative aims to enhance laboratory execution by digitizing workflows and improving quality control testing across North America and Europe. The deployment signifies Charles River's ongoing commitment to modernizing laboratory operations and achieving a fully digital laboratory experience.
AI summary, not financial advice
Share: